HOME › DRUGS › OMBITASVIR;PARITAPREVIR;RITONAVIR
ACTIVE SUBSTANCE / INN

OMBITASVIR;PARITAPREVIR;RITONAVIR

Brand name(s): Viekirax
EMA LISTED
WITHDRAWN
Hepatitis C, Chronic
ACTIVE SUBSTANCE
Ombitasvir;Paritaprevir;Ritonavir
REGULATORS
EMA
SPONSORS / MAH
AbbVie Deutschland GmbH & Co. KG
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
ViekiraxAbbVie Deutschland GmbH & Co. KGWithdrawn14/01/2015Hepatitis C, Chronic

FULL INTELLIGENCE ON OMBITASVIR;PARITAPREVIR;RITONAVIR

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →